|
ИСТИНА |
Войти в систему Регистрация |
Интеллектуальная Система Тематического Исследования НАукометрических данных |
||
NEW AGENT FOR NITRIC OXIDE (NO) CHEMOTHERAPY: SYNTHESIS AND PROPERTIES OF DNIC WITH HYDRAZINIUM CATION IN SOLID PHASE AND SOLUTIONSстатья
- Авторы: Sanina N.A., Kozub G.I., Korchagin D.V., Kondrat'eva T.A., Morgunov R.B., Talantsev A.D., Ovanesyan N.S., Kulikov A.V., Aldoshin S.M., Zhukova O.S.
- Журнал: Journal of Molecular Structure
- Том: 1181
- Год издания: 2019
- Издательство: Elsevier BV
- Местоположение издательства: Netherlands
- Первая страница: 321
- Последняя страница: 326
- Аннотация: New method for the synthesis of the mononuclear anionic iron dinitrosyl complexes (DNICs) as prospective agents for nitric oxide (NO) chemotherapy of oncological diseases has been developed. Mononuclear anionic DNIC of the composition (N2H5)⁺[Fe(SR)2(NO)2]⁻ with R = 5-nitropyridinyl (I) has been synthesized by the reaction of aqueous solutions of Na2[Fе(S2O3)2(NO)2] and N2H5[SС5H3N2O2] salts. The latter one was synthesized by the reduction of bis-(5-nitro-pyridin-2-yl) disulfide with hydrazine hydrate in ethanol at T = 25 °C. Physical-chemical properties of the synthesized complex were studied by X-ray, SEM, IR-, EPR, Mössbauer spectroscopy and SQUID magnetometry in combination with DFT quantum-chemical calculation of molecular structure and spectroscopic properties. Complex I was found to generate NO in proton media without additional activation. The cytotoxicity of I to human tumor cells of various geneses, viz. ovarian cancer SKOV3, colon cancer LS174T and non-small cell lung cancer A549 was discovered for the first time.
- Добавил в систему: Жукова Ольга Степановна